Thus, investigating novel biomarkers to characterize disease status and predict prognosis in cancer patients is highly significant.
← all excerpts
HROB is a novel prognostic biomarker correlated with immune cell infiltration and tumor progression in lung adenocarcinoma.
1
—
—